UPDATE: BMO Capital Downgrades Biogen (BIIB) to Market Perform
Tweet Send to a Friend
(Updated - February 4, 2022 6:45 AM EST)
BMO Capital analyst Evan David Seigerman downgraded Biogen (NASDAQ: BIIB) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
BMO Capital analyst Evan David Seigerman downgraded Biogen (NASDAQ: BIIB) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
